Biosimilar Companies and Market Analysis

The U.S. takes the lion's share (49 percent) of the global biologics market value and generates half of the sales value growth as well. The EU accounts for 22 percent of the market's sales value and 14 percent of its value growth. In contrast, emerging markets represent just a sliver of the sales pie, with 7.5 percent share. Thus, biologics market growth is still largely driven by mature markets. The global biologics market had reached $170 billion in sales value in 2012, accounting for 18 percent of the overall market. The five top 10 global products in terms of sales volume are biologics, wherein 2008 it was just two.

The market in the APAC region for biosimilars reached $605 million in 2010 and $683 million in 2011. The market is expected to reach $1.1 billion by 2016, a CAGR of 10.3%. The market in the United States for biosimilars reached $507 million in 2010 and $1.1 billion in 2011. The market is expected to reach $1.3 billion by 2016, a CAGR of 4.1%.

  • Biosimilars Pharmacoeconomic Modelling
  • Return on Investment(ROI) for Biosimilars
  • CAGR of biologics and biosimilars in USA
  • Penetration and uptake of biosimilars in different disease sectors

Related Conference of Biosimilar Companies and Market Analysis

June 06-07, 2018

International Conference on Pharmaceutical Research and Development

Philadelphia, Pennsylvania, USA
June 08-09, 2018

8th International Conference and Exhibition on GMP, GCP & Quality Control

Philadelphia, Pennsylvania, USA
June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan

3rd International Conference on Generics Drugs and Biosimilars

November 15-17, 2018 | Frankfurt, Germany
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Biosimilar Companies and Market Analysis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in